Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain;Prevalencia del síndrome metabólico y grado de concordancia en su diagnóstico en pacientes con diabetes mellitus tipo 2 en España

Endocrinologia y Nutricion

Volumn 57, Issue 2, 2010, Pages 60-70

  Rodríguez Bernardino, Ángel ^a   García Polavieja, Pepa ^a   Reviriego Fernández, Jesús ^a   Serrano Ríos, Manuel ^b  

^a ELI LILLY AND COMPANY   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Diagnosis; Metabolic syndrome; Prevalence; Spain; Type 2 diabetes mellitus

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SPAIN; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERNATIONAL AGENCIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEDENTARY LIFESTYLE; SPAIN; WORLD HEALTH ORGANIZATION;

EID: 77949485986     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2009.12.002     Document Type: Article

References (25)

1. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., and Shaw J. The metabolic Syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12 (2005) 295-300
2. Zimmet P.Z. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42 (1999) 499-518
3. Reaven G.M. Banting lecture 1988. Role of insuline resistance in human disease. Diabetes 37 (1988) 1595-1607
4. Guize L., Pannier B., Thomas F., Bean K., Jégo B., and Benetos A. Recent advances in metabolic syndrome and cardiovascular disease. Arch Cardiovasc Dis 101 (2008) 577-583
5. Ruige J.B., Assendelft W.J.J., Dekker J.M., Kostense P.J., Heine R.J., and Bouter L.M. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 97 (1998) 996-1001
6. Olijhoek J.K., van der Graaf Y., Banga J.D., Algra A., Rabelink T.J., Visseren F.L., and the SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 25 (2004) 342-348
7. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-1.
9. Balkau B., Charles M.A., Drivsholm T., Borch-Johnsen K., Wareham N., Yudkin J.S., et al. Frequency of the WHO metabolic syndrome in European cohorts, and alternative definition of an insulin resistance syndrome. Diabetes Metab 28 (2002) 364-376
10. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
11. Alvarez León E.E., Ribas Barba L., and Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc) 120 (2003) 172-174
12. Ascaso J.F., Gabriel R., Franch J., Godoy A., Fernández de Bobadilla J., Ortega R., et al. Grado de concordancia de los distintos criterios que definen el síndrome metabólico en el estudio DESIRE. Av Diabetol (2004) 20-23
13. Relimpio F., Martinez-Brocca M.A., Leal-Cerro A., Losada F., Mangas M.A., Pumar A., et al. Variability in the presence of the metabolic sindrome in Type 2 diabetic patients attending a diabetes clinic. Influences of age and gender. Diabetes Res Clin Pract 65 (2004) 135-142
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005; 28: S37-2.
15. Rao R.S., Glickman M.E., and Glynn R.J. Use of covariates and survey wave to adjust for nonresponse. Biom J 46 (2004) 579-588
16. Marrugat J., Solanas P., D'Agostino R., Sullivan L., Ordovas J., Cordón F., et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 56 (2003) 253-261
17. Ilanne-Parikka P., Eriksson J.G., Lindström J., Hämäläinen H., Keinänen-Kiukaanniemi S., Laakso M., et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 27 (2004) 2135-2140
18. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
19. Gimeno J.A., Lou L.M., Molinero E., Boned B., and Portilla D.P. Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Rev Esp Cardiol 57 (2004) 507-513
20. Martínez Candela J., Franch Nadal J., Romero Ortiz J., Cánovas Domínguez C., Gallardo Martín A., and Páez Pérez M. Prevalencia del síndrome metabólico en la población adulta de Yecla (Murcia). Grado de acuerdo entre tres definiciones. Aten Primaria 38 (2006) 72-79
21. Lorenzo C., Serrano-Ríos M., Martínez-Larrad M.T., Gabriel R., Williams K., Gómez-Gerique J.A., et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 11 (2003) 1480-1487
22. Liu J., Young T.K., Zinman B., Harris S.B., Connelly P.W., and Hanley A.J. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity (Silver Spring) 14 (2006) 500-508
23. Mohan V., Gokulakrishnan K., Deepa R., Shanthirani C.S., and Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15). Diabet Med 22 (2005) 1206-1211
24. Boronat M., Chirino R., Varillas V.F., Saavedra P., Marrero D., Fábregas M., et al. Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med 22 (2005) 1751-1756
25. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., and Donato K.A. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. Circulation 120 (2009) 1640-1645